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Abstract
Background: Adult skeletal stem cells (SSCs) often exhibit limited in vitro expansion with undesirable phenotypic
changes and loss of differentiation capacity. Foetal tissues offer an alternative cell source, providing SSCs which
exhibit desirable differentiation capacity over prolonged periods, ideal for extensive in vitro and ex vivo investigation
of fundamental bone biology and skeletal development.
Methods: We have examined the derivation of distinct cell populations from human foetal femora. Regionally
isolated populations including epiphyseal and diaphyseal cells were carefully dissected. Expression of the SSC
marker Stro-1 was also found in human foetal femora over a range of developmental stages and subsequently
utilised for immuno-selection.
Results: Regional populations exhibited chondrogenic (epiphyseal) and osteogenic (diaphyseal) phenotypes
following in vitro and ex vivo characterisation and molecular analysis, indicative of native SSC maturation during
skeletal development. However, each population exhibited potential for induced multi-lineage differentiation
towards bone (bone nodule formation), cartilage (proteoglycan and mucopolysaccharide deposition) and fat
(lipid deposition), suggesting the presence of a shared stem cell sub-population. This shared sub-population
may be comprised of Stro-1+ cells, which were later identified and immuno-selected from whole foetal femora
exhibiting multi-lineage differentiation capacity in vitro and ex vivo.
Conclusions: Distinct populations were isolated from human foetal femora expressing osteochondral differentiation
capacity. Stro-1 immuno-selected SSCs were isolated from whole femora expressing desirable multi-lineage
differentiation capacity over prolonged in vitro expansion, superior to their adult-derived counterparts,
providing a valuable cell source with which to study bone biology and skeletal development.
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Background
Bone damage and loss due to disease and trauma is a
growing concern for an increasingly aged population.
Many methods exist to repair bone defects including
auto- and allografts, and de novo tissue engineering
[1–4]. However, a major limitation of reparative strat-
egies is fully understanding the biological mechanisms
controlling skeletal development. Elucidation of native
development and healing would inevitably improve suc-
cessful bone defect treatment, whether by reparation,
replacement or regeneration. To investigate basic hu-
man bone biology and understand the fundamental
mechanisms of bone formation and repair, a robust
in vitro/ex vivo developmental paradigm representative
of native skeletal development is required. A critical
step in this approach is the identification and isolation
of osteoprogenitor cells capable of osteochondral differ-
entiation to inform bone regeneration and augmenta-
tion [5–7]. Furthermore, a homogeneous bone stem
cell population would enable interrogation of skeletal
development and aid screening for reparative strategies,
including osteoconductive scaffolds and osteoinductive
signalling molecules and mechanical cues [8, 9].
Adult human bone marrow stromal cells (HBMSCs)
contain a diminutive bone stem cell population (1 in
10,000 to 50,000) often referred to as mesenchymal stem
cells (MSCs), which exhibit osteochondral differentiation
capacity [10–12]. MSCs have been shown in a number
of studies to generate tissues of the in vivo musculoskel-
etal system including bone, cartilage, fat, ligament,
muscle and tendon [10, 13–17]. However, conventional
MSC populations are highly heterogeneous and contro-
versy over their exact identity and differentiation potential
remains with reports of hepatocyte and neuronal differen-
tiation [18, 19]. The observed heterogeneity [20, 21] is
likely a consequence of their derivation from a multi-
tude of adult tissues including dental pulp, fat, muscle,
skin, synovium [22–27], and extra-embryonic tissues
including amniotic fluid, placenta and umbilical cord
blood [28–31]. This highlights the need for robust
in vitro clonal analysis and in vivo validation of exact
differentiation capacity. The exact phenotype is more
than scientific pedantry as heterogeneity impacts on
MSC suitability for clinical application, demanding an
additional purification step either before controlled differ-
entiation (isolation of a homogeneous stem cell popula-
tion) [6] or following heterogeneous differentiation
(isolation of specific terminally differentiated cell types)
[32]. Given the imprecise nature and often misappropriate
use of the term MSC (typically almost any adherent fibro-
blastic cell population, as well as the observation that
MSCs from different tissues are not the same), we have
used the term skeletal stem cell (SSC) [2, 33–35] in refer-
ence to the stem cell population with specific differentiation
capacity (haematopoietic supportive stroma) towards all
skeletal tissues including bone, cartilage, and fat [9, 36–38].
An alternative cell source to adult tissue, yet controver-
sial, is foetal tissue which has been shown to contain cell
populations with comparable if not enhanced reparative
function [39–42]. Foetal femora are composed of prolifera-
tive osteochondral progenitor cells capable of self-renewal,
differentiation and bone and cartilage formation. During
development, these populations exhibit regional differences
driving endochondral ossification and formation of long
bones. The epiphyseal region is predominantly cartilagin-
ous, whilst the diaphyseal region undergoes mineralisation
and bone formation. Cell populations isolated from these
separate regions would help delineate the sequential bio-
logical mechanisms driving bone formation and inform ef-
forts to improve bone repair and regeneration. As in adult
tissues, foetal SSCs constitute osteochondral progenitors
capable of cartilage and bone formation, and the authors
hypothesise that both epiphyseal and diaphyseal popula-
tions share this SSC sub-population.
One surface marker which has shown robust enrichment
specificity for SSCs is trypsin-resistant cell surface antigen
1 (Stro-1) [43–46]. Adult Stro-1+ populations exhibit en-
hanced colony forming unit–fibroblastic (CFU-F) capacity
and elevated osteogenic differentiation both in vitro and in
vivo in comparison to unsorted adult HBMSCs [47–50].
Consequently, Stro-1 expression was sought in human
foetal femora to identify possible foetal SSCs. Previous
work has shown that whole foetal femur-derived cell popu-
lations offer an alternative to adult populations, specifically
for in vitro investigation of human skeletal development,
displaying significantly enhanced proliferation and multi-
lineage differentiation capacity [5, 51–55]. Furthermore,
studies have demonstrated significant enhancement of
bone defect repair following application of whole foetal
femur-derived cell populations in biodegradable carrier
scaffolds [56–59].
The current study has isolated and characterised a Stro-
1+ sub-population in whole foetal femora, representing
foetal femur-derived SSCs. Specifically, we have examined
the potential of foetal femur tissue as a source of inducible
SSCs, built on the premise that distinct regional cell popu-
lations could be routinely derived exhibiting specific chon-
drogenic and osteogenic differentiation capacity, and that
Stro-1 enrichment could target a SSC sub-population.
These populations could provide the necessary in vitro/
ex vivo investigative tools to elucidate bone biology
mechanisms active during skeletal development.
Methods
All tissue culture reagents, growth factors, chemicals and
other materials were supplied by Sigma Aldrich unless
otherwise stated. Collagen type I polyclonal antibody was
a kind gift from Dr. Larry Fisher (National Institutes of
Gothard et al. Stem Cell Research & Therapy  (2015) 6:251 Page 2 of 17
Health (NIH)). Hydroxyapatite-loaded poly-lactic acid
scaffolds (HA-PLA) were kindly provided by Dr. Lisa
White, University of Nottingham. Stro-1 hybridoma was
re-derived from an original donation provided by Dr. Jon
N. Beresford, University of Bath [44, 60]. Fertilized
chicken eggs were supplied by Henry Stewart & Co. Ltd,
Fakenham, Norfolk, NR21 8LZ, United Kingdom.
Ethics statement
Foetal tissue was obtained following informed consent and
ethical approval from the National Research Ethics Com-
mittee South Central-Southampton (REC 296/00296100).
All animal procedures were carried out in accordance with
the guidelines and regulations laid down in the Animals
(Scientific Procedures) Act 1986. As part of the application
for a project licence under which to perform the animal
work, animal procedures in this study were reviewed and
approved by the Scientific Review Group, part of the Ani-
mal Welfare and Ethical Review Body at the University of
Southampton. Chick embryos were sacrificed at embryonic
day 11 by schedule 1 decapitation according to Home Of-
fice Approval UK (Project license – PPL 30/2762). Femora
were dissected from embryonic day 11 chick embryos
(Gallus domesticus), and soft tissue was carefully removed.
Cell isolation and culture
Human foetal femur preparation
Femora were obtained following termination of preg-
nancy and informed patient consent. Foetal age was de-
termined according to foot length and expressed as days
post-conception. Samples ranged from 53 to 69 days
(4 mm to 8.5 mm) [5, 61]. Femora were dissected and
surrounding soft tissues were removed by gentle rolling
back and forth across sterile filter paper. Soft tissues
stuck to the filter paper whilst the femur was separated
cleanly. Dependent on the developmental stage of each
sample, the periosteum was removed manually by dis-
section (older samples) or as part of the preparation pro-
cedure (younger samples).
Epiphyseal and diaphyseal cell isolation
Prepared femora were dissected into epiphyseal and diaphy-
seal regions via a transverse incision through the metaphy-
sis region at either end of the bone collar (Additional file 1:
Figure S1). The bone collar distinguished the boundary be-
tween the diaphysis and epiphyses. Both proximal and dis-
tal epiphyses were combined in each sample and carefully
cut into small segments, as was the diaphysis separately,
prior to overnight collagenase B (Roche Products Limited
(Pharmaceuticals), Welwyn Garden City, AL7 1TW, United
Kingdom) digestion (1 mg/mL in minimum essential
medium – alpha [α-MEM, Life Technologies Ltd, Thermo
Fisher Scientific, Paisley, PA4 9RF, United Kingdom]) at
37 °C. Isolated cells were cultured in basal medium.
SSC isolation
Whole femora were cut into small segments and collage-
nase B digested overnight in preparation for Stro-1
immuno-selection. Most of the tissue was completely
digested, however, individual isolated cells were passed
through a 40 μm sieve (BD Biosciences, Oxford Science
Park, Oxford OX4 4DQ, United Kingdom) to remove
large clumps and mineralised bone collar, and suspended
in basal medium (α-MEM, 10 % foetal calf serum (FCS,
Invitrogen, Thermo Fisher Scientific, Paisley, PA4 9RF,
United Kingdom), penicillin (100 U/mL, PAA Laborator-
ies Ltd, Yeovil, Somerset, BA22 8YG, United Kingdom),
and streptomycin (0.1 mg/mL, PAA Laboratories Ltd,
Yeovil, Somerset, BA22 8YG, United Kingdom)). Cells
were initially incubated with blocking buffer (α-MEM,
10 % human serum, 5 % FCS and 1 % bovine serum al-
bumin (BSA, PAA Laboratories Ltd, Yeovil, Somerset,
BA22 8YG, United Kingdom)) before incubation with
primary Stro-1 antibody (undiluted hybridoma culture
supernatant) [62]. Suspensions were subsequently washed
three times in isolation buffer (2 mM ethylenediaminetet-
raacetic acid [EDTA] and 1 % BSA in phosphate buffered
saline [PBS]) before incubation with magnetic bead-
conjugated secondary antibody (200 μL in 1 mL isolation
buffer, Miltenyi Biotec Ltd, Woking, Surrey GU24 9DR,
United Kingdom). Samples were then washed and target
cells isolated by magnetic-activated cell sorting (MACS)
prior to suspension and culture in basal medium.
Adult SSC isolation
Adult Stro-1 populations were isolated as detailed above.
In brief, bone marrow was isolated from haematologically
normal osteoarthritic patients undergoing total hip re-
placement at the Southampton General Hospital with
informed consent (approval from the Southampton and
South West Hampshire Local Research Ethics Committee
[LREC194/99]). Bone marrow was sieved to remove blood
clots and bone fragments and treated with a density
gradient solution (Lymphoprep™, Lonza, Slough, Berk-
shire, SL1 4DX, United Kingdom) to remove erythro-
cytes. The remaining cell suspension was then
immuno-labelled with Stro-1 and sorted by MACS.
Control unsorted cell populations were separated from
each sample before Stro-1 antibody labelling. Unsorted
cells were processed in parallel in PBS. Isolated cell popu-
lations were suspended and cultured in basal medium.
Cell characterisation
Alkaline phosphatase expression
Cultures (P1) were PBS washed 3 h after seeding into
culture flasks to remove non-adhered cells, and incu-
bated for 14 days without basal medium change at 37 °C,
5 % CO2 in a humidified atmosphere. Cultures were fixed
with 85 % ethanol before air drying then incubation with
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Fast Violet B salt (2.5 μg/mL) and Naphthol AS-MX phos-
phate (40 μL/mL) in dH2O for 30-45 min at 37 °C and
5 % CO2 in a humidified atmosphere under dark condi-
tions. Cultures were then washed with H2O and counter-
stained in haematoxylin for 5 min. Cultures were washed
with H2O again and left to air dry prior to quantification.
Seeding densities were selected based on whether clear
colonies could be observed following qualitative assess-
ment of a series of seeding densities including 0.5 × 101,
1 × 101, 1 × 102, and 1 × 103 cells/cm2.
Specific alkaline phosphatase activity
Samples were fixed in 85 % ethanol before treatment with
0.05 % Triton™ X-100 and three freeze-thaw cycles. DNA
quantification was assessed by diluting cell lysate with
Tris/EDTA buffer and addition of Quant-iT™ PicoGreen®
dsDNA reagent (Life Technologies). Alkaline phosphatase
(ALP) activity was assessed by diluting cell lysate in ALP
substrate solution (2 mg/mL p-nitrophenyl phosphate
[pNPP] in 0.75 M alkaline buffer solution). Samples were
then incubated at 37 °C in the dark, under gentle agita-
tion, and the reaction was terminated with 1 M sodium
hydroxide after 45-60 min. Spectrophotometry was used
to quantify DNA and ALP activity at 530 nm and 405 nm,
respectively. ALP concentration was measured in nmol
pNPP/mL h-1, and ALP activity in nmol pNPP/μg DNA.
Differentiation culture – monolayer/micromass
Osteogenesis
Cells (P2) were seeded at 1 × 103 cell/cm2 and cultured in
osteogenic medium (α-MEM, 10 % FCS, 10 nM dexa-
methasone [Dex] and 100 μM ascorbate-2-phosphate
[Asc]) for 14 days. Osteogenic medium was supplemented
with 10 mM β-glycerophosphate to enable bone nodule
formation. Cultures were fixed in 4 % paraformaldehyde
(PFA) and stained with Alizarin red (1 % w/v in dH2O).
Chondrogenesis
A total of 2.5 × 105 cells (P2) per micromass were sus-
pended in 10-20 μL basal medium, pipetted carefully into
a six-well plate and incubated for 1 h allowing attachment
to the plate and cell/cell adhesion. Basal medium was re-
moved and chondrogenic medium (α-MEM, 10 nM Dex,
100 μM Asc, 10 ng/mL TGFβ-3 [Peprotech, London, W6
8LL, United Kingdom]) and 10 μg/mL insulin (in the form
of 100× insulin/tranferrin/sodium selenite [ITS] solution)
was carefully added so as to not disturb the micromass.
After 21 days, cultures were fixed in 4 % PFA and stained
with Alcian blue (0.5 % w/v in acidic H2O [0.01 % acetic
acid]).
Adipogenesis
Cells (P2) were seeded at 1 × 103 cell/cm2 and cultured
in adipogenic medium (α-MEM, 10 % FCS, 1 μM Dex,
0.5 mM 3-isobutyl-1-methylxanthine [IBMX], 100 μM
indomethacin and 10 μg/mL ITS solution) for three days
followed by one day in ITS only medium (α-MEM, 10 %
FCS and 10 μg/mL ITS solution). This was repeated
three times before continuous culture in ITS medium
up to 28 days. Cultures were fixed in Baker’s formal cal-
cium (0.1 g/mL calcium chloride in 4 % formaldehyde),
rinsed with 60 % isopropanol, and stained with a filtered
working solution (3:2 in dH2O) of stock Oil Red O
(powder saturated 99 % isopropanol) for 15 min. Alter-
native adipogenic medium (α-MEM, 10 % FCS, 100 nM
Dex, 0.5 mM IBMX, 3 μg/mL ITS solution and 1 μM
rosiglitazone) was utilised for later differentiation cultures.
Revised adipogenic medium was observed to induce lipid
formation within 14 days.
All cultures received medium changes twice weekly.
All differentiation media were not supplemented with
penicillin and streptomycin. Following revised adipo-
genic medium, all diaphyseal and epiphyseal differenti-
ation cultures were revised to a total 14 day culture
period.
3D pellet formation and organotypic culture
Epiphyseal and diaphyseal populations were cultured as
pellets (2.5 × 105 cells per pellet [P2]) in basal medium for
48 h to allow formation before transfer to organotypic cul-
ture on polytetrafluoroethylene (PTFE) confetti membranes
(BioCell Interface, La Chaux-de-Fonds, Switzerland) on
tissue culture flask-well inserts. Organotypic pellets were
cultured for 21 days in either basal, osteogenic or chondro-
genic medium (detailed previously). After 21 days, pellets
were processed and assessed for ALP activity as described
previously.
Histomorphometry analysis
Following differentiation culture and histological staining,
three or five representative images (unsorted vs Stro-1,
and epiphyseal vs diaphyseal, respectively) across each
sample well (triplicate wells) were used to quantify differ-
entiation. CellProfiler image software was employed to
quantify the area (cm2) of stain per 105 cells (cell nuclei
were counterstained with DAPI and imaged by fluores-
cence microscopy). Following micromass culture in chon-
drogenic medium, histological staining and imaging, Fiji
(Image J) image software was used to quantify mean
colour intensity in individual micromass pellets (triplicate
wells per sample: one to three micromass pellets per
well, epiphyseal vs diaphyseal, and unsorted vs Stro-1,
respectively). Colour quantification was achieved
through greyscale conversion and assessment of mean
intensity across the diameter of the micromass pellet
(0 to 255 scale; black through to white): values were
inverted so 0 was white and 255 was black.
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Molecular analysis
MirVana™ RNA Isolation System Kit (Life Technologies)
was used for RNA extraction according to the manufac-
turer’s protocol following 14 days culture in basal condi-
tions. Cultured samples were placed on ice and washed
twice in PBS. Lysis buffer and a homogenizing agent were
used to liberate RNA from cells, followed by acid phenol-
chloroform. The resultant mixture was centrifuged to allow
phase separation. The RNA-containing aqueous phase was
removed and added to ethanol prior to elution through a
spin column. The column was washed three times with
supplied buffer solutions and RNA eluted in RNase free
water.
For cDNA synthesis, SuperScript® VILO cDNA Synthe-
sis Kit (Life Technologies) was used for cDNA synthesis.
RNA was combined with 5x VILO™ reaction mix and 1 μL
of 10x SuperScript® enzyme was added to RNA samples
and incubated at 25 °C for 10 min followed by 42 °C for
2 hr. The reaction was terminated by incubation at 85 °C
for 5 min. Then, 40 μL of ultra-pure H2O (upH2O) was
added to the cDNA sample to give a 1:4 dilution and
stored at -20 °C or used immediately for quantitative
RT-qPCR analysis. Quantitative RT-qPCR was performed
using SYBR-Green PCR master mix (Life Technologies):
10 μL of SYBR-Green master mix; 5 μL of upH2O; 2 μL of
forward and reverse primers for the gene of interest
(Additional file 2: Table S1) and 1 μL of cDNA sample.
The final mixture (20 μL) was added to each well of a
96-well-plate, analyzed using an Applied Biosystem (Life
Technologies), 7500 Real Time PCR system. Data gener-
ated by RT-qPCR were analysed using the Applied Bio-
system 7500 System SDS Software, version 2.0.5. Ct value
(cycle threshold) for each sample was normalized to β-
actin, an endogenous housekeeping gene, and fold expres-
sion levels for each target gene were calculated using the
delta-delta Ct method.
Ex vivo tissue regeneration
Chick femora isolation
Fertilized eggs were incubated (Hatchmaster, Brinsea
Products Ltd, Weston Industrial Estate, Weston Super
Mare, BS24 9BG, United Kingdom) for 11 days. Chick em-
bryos were euthanized by decapitation prior to bilateral
dissection of femora. Surrounding soft tissue was removed
from the femora before overnight incubation in basal
medium [63, 64].
Defect preparation and 3D pellet implantation
Following test defects using a 300 μm diameter drill
(Additional file 3: Figure S2), a diaphyseal defect was po-
sitioned centrally along the length of the femur, and epi-
physeal defects were positioned halfway between the end
of the femur and the end of the bone collar. The femurs
continue to grow and the tissues swell during the 10-day
culture period contributing to partial closure of the de-
fects. However, the defects are still visible after 10 days
without implantation of cell pellets. Drill defects were
plugged with appropriate preformed cell pellets (1.5 × 104
cells [P2] per pellet, centrifuged at 1,000 rpm for 4 min,
and incubated for 48 h in basal medium) and cultured
organotypically on well inserts for 10 days in α-MEM with
100 μM Asc. Medium was changed every day before 4 %
PFA fixation. A standard curve detailing the correlation
between cell number (1 × 104, 5 × 104, 1 × 105, 2.5 × 105,
5 × 105, and 1 × 106 cells) and pellet diameter was used to
assess the appropriate cell number required to generate a
300 μm diameter pellet (Additional file 4: Figure S3).
Ex vivo chick femur defects offered a simple and rela-
tively rapid model for assessment of differentiation and
tissue regeneration capacity inherent to distinct isolated
populations. The advantage of the system is that it offers
a high throughput skeletal model for screening candidate
cell populations prior to expensive and time consuming
in vivo models. Previous work in the group has shown
that organotypic culture beyond 10 days has detrimental
effects on cell viability in the femora. Embryonic day 11
chick femora were selected due to the presence of an
osteogenic phenotype dominating the diaphyseal region
with bone collar formation, and a chondrogenic phenotype
dominating the epiphyseal regions. Both environments
were required to assess the osteochondral differentiation
capacity of implanted pellets.
Histological analysis
Sample preparation and sectioning
Pellets and organotypic femora were fixed in 4 % PFA
for 24 h, dehydrated through a series of ethanol washes
(50 %, 70 %, 90 % in dH2O, and 2 × 100 %, 1 h in each),
and incubated in Histo-Clear (National Diagnostics UK,
Unit 4 Fleet Business Park, East Riding of Yorkshire,
HU139LX, United Kingdom) for 1 h prior to paraffin
wax at 60 °C (1 h). Processed samples were subsequently
embedded in wax blocks using an automated Shandon
Citadel 2000 ready for histological assessment. Embed-
ded samples were sectioned at a thickness of 7 μm using
a Microm HM330 D-6900 microtome (Heidelberg In-
struments, Tullastraße 2, 69126 Heidelberg, Germany).
All sections from pellets and femora were collected. Sec-
tions were stained, washed in water, dehydrated where
appropriate and mounted with DPX before imaging on an
Olympus BX-51/22 dotSlide digital virtual microscope
using OlyVIA 2.1 software (Olympus Soft Imaging Solu-
tions GmbH, Johann-Krane-Weg, 3948149 Münster,
Germany, GmBH).
Alcian blue/Sirius red
Slides were de-waxed and rehydrated before treatment
with haematoxylin (10 min), followed by acid-alcohol
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dip and treatment with Alcian blue (10 min – 0.5 % w/
v), molybdophosphoric acid (10-20 min – 1 % w/v) and
Sirius red (45-60 min - 0.1 % w/v in 100 mL picric acid
and 200 mL dH20).
Von Kossa
Slides were de-waxed and rehydrated before treatment
with 1 % silver nitrate under UV irradiation for 20 min.
Slides were then treated with 2.5 % sodium thiosulfate
(8 min) and counterstained with Alcian blue (1 min) and
van Gieson (5 min – 0.9 mg/mL Acid Fucshin in 50 %
Picric acid).
Goldner’s Trichrome
Slides were de-waxed and rehydrated before treatment
with haematoxylin (10 min), followed by acid/alcohol
dip. Slides were treated for 5 min with 10 % v/v
ponceau-fuchsin (0.75 % w/v and 0.25 % w/v, respect-
ively, in 1 % acetic acid) and 2 % v/v azophloxin solution
(0.5 % w/v in 0.6 % acetic acid) in acetic acid (0.2 % in
dH2O). Slides were subsequently treated with 0.6 % w/v
phosphomolybdic acid and 0.4 % w/v orange G solution
in dH2O with thymol (20 min) before counterstaining
with 0.2 % w/v light green solution in 0.2 % acetic acid.
Stained sections were blotted dry and directly mounted
with DPX.
Birefringence
Organotypic femora following Alcian blue/Sirius red (A/S)
staining were also imaged using polarising filters to assess
birefringence in implanted pellets by light microscopy.
Femora were preferentially sectioned in the longitudinal
plane to enable defect visualisation in the same section.
Sections were oriented to follow the path of the drill
defect through the femur to aid implant localisation.
Birefringence colour correlated with collagen fibre align-
ment. Highly aligned collagen fibres in mineralised bone
appeared red, whilst less aligned collagen fibres in pre-
mineralised bone appeared yellow, and in osteoid ap-
peared green.
Immunochemistry
Sample sections were de-waxed and rehydrated before
hydrogen peroxide (3 % in dH2O) quenching of en-
dogenous peroxidase activity. Sections were incubated
with blocking buffer (1 % BSA in PBS) for 15 min then
primary antibody solution (1:1,000 COL1A1 (LF69),
1:500 COL2A1 (Cabiochem, Merck Millipore Ltd, Fel-
tham, Middlesex, TW14 8NX, United Kingdom) and
1:50 SOX9 [Abcam, Cambridge Science Park, Cam-
bridge, CB4 0FL, United Kingdom]) overnight at 4 °C.
Biotinylated secondary antibody (1:200 in blocking buf-
fer) was applied for 1 h before incubation with avidin-
conjugated peroxidase. Finally, sections were treated
with 3-amino-9-ethylcarbazole for 10 min until visualisa-
tion of a red-brown reaction product [5]. Sections were
washed between steps with blocking buffer and mounted
with Fluoromount™ once stained. Negative controls were
run alongside lacking the respective primary antibody
before imaging on dotSlide.
Statistical analysis
A non-parametric Mann Whitney or Wilcoxon test was
employed to assess significance between unpaired and
paired data sets, respectively. Results are presented as
mean ± SD. Significance is depicted by * P ≤ 0.05, ** P ≤ 0.01,
*** P ≤ 0.001.
Results
Characterisation of foetal femur cell populations isolated
by region
2D characterisation of epiphyseal and diaphyseal
populations in vitro
Following isolation and in vitro culture, both epiphyseal
and diaphyseal populations exhibited similar colony for-
mation capacity (Fig. 1a). However, diaphyseal populations
exhibited significantly (P ≤ 0.05) enhanced ALP+ colony
formation with an approximate three-fold increase
(Fig. 1b).
Basal cultures of epiphyseal and diaphyseal populations
were assessed by molecular analysis for a selection of
osteochondral genes (Fig. 1). Diaphyseal populations ex-
hibited significantly increased expression of osteogenic
genes including RUNX2 (8.4 fold, P ≤ 0.001), ALP (8.6
fold, P ≤ 0.001), collagen type 1 (COL1A1, 2.3 fold, P ≤
0.01) and osteonectin (ON, 1.6 fold, P ≤ 0.01) (Fig. 1c to f,
respectively). Osterix (OSX) expression appeared greater
in diaphyseal populations, although this did not reach sig-
nificance (Fig. 1g). Osteocalcin (OCN) expression, a late
osteogenesis marker, was significantly (P ≤ 0.01) reduced
in diaphyseal compared to epiphyseal populations (Fig. 1h).
Early chondrogenesis marker expression was significantly
reduced in diaphyseal populations for genes including
SOX9 (1.5 fold, P ≤ 0.05) and collagen type 2 (COL2A1,
20 fold, P ≤ 0.01) (Fig. 1i and j). Interestingly, collagen type
10 (COL10A1) expression, a late chondrogenesis marker,
was significantly (P ≤ 0.01) increased in diaphyseal popula-
tions (Fig. 1k).
High ALP expression in diaphyseal populations corre-
lated with significantly (P ≤ 0.001) increased calcification
(Alizarin red stained bone nodule formation) and signifi-
cantly (P ≤ 0.001) decreased lipid deposition (Oil Red O
stained lipid deposition) (Fig. 2a and b, respectively)
following differentiation culture. Cartilaginous matrix
formation was also significantly (P ≤ 0.05) decreased in
diaphyseal compared to epiphyseal populations (Alcian
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blue stained proteoglycan/mucopolysaccharide depos-
ition) (Fig. 2c).
3D characterisation of epiphyseal and diaphyseal
populations in vitro
Diaphyseal 3D pellets exhibited significant (P ≤ 0.05) up-
regulation of osteogenic genes including ALP (2.9 fold),
COL1A1 (1.8) and RUNX2 (3.8 fold) compared with epi-
physeal 3D pellets (Fig. 3a to c). Results were similar to
those observed in monolayer cultures under basal condi-
tions; however, no significant differences were observed in
ON expression between epiphyseal and diaphyseal pellets
(Fig. 3d), and neither OCN nor OSX were expressed (data
not shown). Although expression of the chondrogenic
gene COL2A1 was similar to that in monolayer cultures
under basal conditions with a three-fold downregulation
in diaphyseal pellets (Fig. 3e), no significant difference in
SOX9 expression (Fig. 3e) was observed, and COL10A1
expression was reversed with a 2.5 fold downregulation in
diaphyseal pellets (Fig. 3f).
Histological analysis revealed greater collagen depos-
ition following differentiation culture compared to basal
conditions (Fig. 4). However, both basal and differentiation
culture exhibited both COL1A1 and COL2A1 deposition
in epiphyseal and diaphyseal pellets. Interestingly, only
epiphyseal pellets cultured in chondrogenic media exhib-
ited SOX9 expression and osteoid formation. In addition,
only diaphyseal pellets, independent of culture medium,
exhibited mineralised tissue formation.
Ex vivo differentiation capacity in epiphyseal and
diaphyseal cell populations
In marked contrast to control defects with no implants
which remained empty (Additional file 3: Figure S2), all
defects implanted with cell pellets exhibited new tissue for-
mation (Fig. 5). Epiphyseal defects exhibited proteoglycan-
rich tissue, whilst diaphyseal defects exhibited collagen
deposition, independent of pellet type. Both epiphyseal
(Fig. 5b) and diaphyseal pellets (Fig. 5a) demonstrated new
matrix deposition relative to the implantation site, possibly
due to local inductive signalling cues. Birefringence im-
aging showed that fibre alignment within new collagen de-
posits was comparable to that in native mineralised tissue
(Fig. 5a).
Fig. 1 ALP expression and molecular analysis of epiphyseal and diaphyseal populations. Isolated cell populations (P1) were seeded into CFU-F
assay (1 × 101 cells/cm2) and cultured for 14 days prior to quantification of ALP+ colonies a and b. Populations were cultured in T25 cm2 flasks,
and colonies were counted from the whole flask. ALP+ colonies are presented as a percentage of the total number of colonies. Molecular analysis
in epiphyseal and diaphyseal populations assessed expression of osteochondral genes after 14 days culture in basal medium, including OSX c, RUNX2
d, ALP e, COL1A1 f, ON g, OCN h, COL10A1 i, SOX9 j, and COL2A1 k. Error bars are SD. * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001 (foetal samples, n = 3; 55 61
and 63 days post conception). ALP alkaline phosphatase, CFU-F colony forming unit – fibroblastic
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Characterisation of foetal femur cell populations isolated
by Stro-1 immuno-selection
Human foetal femur development and Stro-1 expression
During development between 47 and 69 days post con-
ception (age range of acquired samples in this study),
human foetal femurs significantly increase in size with
mineralised bone collar formation between 53 and
54 days (white arrows) and marrow invasion between
59 and 67 days (Additional file 5: Figure S4). White
arrows point at the bone collar. Interestingly, Stro-1
expression in the femur loosely correlated with these
developmental stages (Additional file 6: Figure S5). Early
Stro-1 expression was observed around 47 days post con-
ception prior to bone collar formation. Once bone collar
formation began, Stro-1 expression was again observed
between 55 and 61 days. Expression was not observed fol-
lowing marrow invasion.
2D characterisation of Stro-1 immuno-selected cell
populations
Stro-1 expression was observed in monolayer cultures
over five serial passages, with a rapid reduction in Stro-1
expression after passage 6 and loss of expression after
passage 7 (Additional file 7: Figure S6). No change in
colony formation capacity over serial passage was observed
(Fig. 6a). However, ALP+ colony formation capacity signifi-
cantly (P ≤ 0.01) decreased over serial passage (Fig. 6b).
Loss of ALP+ colony formation capacity appeared to cor-
relate with significantly (P ≤ 0.01) increased population
doubling rate; however, correlation was not specifically
assessed (Fig. 6c). Interestingly, ALP activity appeared
unchanged over serial passage (Fig. 6d), but significantly
(P ≤ 0.001) increased following osteogenic culture (Fig. 6e).
Significantly (P ≤ 0.001) enhanced calcium deposition and
nodule formation was observed in both unsorted and Stro-
Fig. 2 Multi-lineage differentiation potential of epiphyseal and diaphyseal populations. Monolayer cultures (P2) were seeded at 1 × 103 cell/cm2,
treated with osteogenic and adipogenic (rosiglitazone) medium for 14 days and stained with Alizarin red a and Oil Red O b, respectively. Micromass
cultures (2.5 × 105 cells per pellet) were treated with chondrogenic medium for 14 days and stained with Alcian blue c. Error bars are SD.
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 (foetal samples, n = 3; 53, 54 and 63 days post conception)
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1 immuno-selected populations following osteogenic com-
pared to basal culture (Fig. 6f). Stro-1 immuno-selected
populations exhibited significantly (P ≤ 0.001) increased
nodule formation even in the absence of osteogenic induc-
tion. Both populations exhibited significantly increased
(P ≤ 0.001) lipid formation following adipogenic culture,
but Stro-1 immuno-selected populations exhibited signifi-
cantly (P ≤ 0.001) higher lipid formation compared to un-
sorted populations (Fig. 6g). Proteoglycan deposition
significantly (P ≤ 0.001) increased equally in both unsorted
and Stro-1 immuno-selected populations following chon-
drogenic culture (Fig. 6h).
In comparison to adult Stro-1 immuno-selected pop-
ulations which are known to exhibit decreased Stro-1
expression following in vitro expansion, foetal Stro-1
immuno-selected populations exhibited phenotype stabil-
ity over several passages [60]. Furthermore, multi-lineage
in vitro differentiation potential was shown to correlate
with Stro-1 expression over early (P2) and late (P6) pas-
sage (Additional file 8: Figure S7). Osteogenic and
chondrogenic differentiation were observed without in-
duction, highlighting a preference towards these lineages.
In basal cultures, adipogenic differentiation was observed
at early (P2) but not late (P6) passage.
Ex vivo differentiation capacity in Stro-1 immuno-selected
cell populations
Unsorted pellets exhibited negligible new matrix forma-
tion in both epiphyseal and diaphyseal defects (Fig. 7). In
marked contrast, Stro-1 immuno-selected pellets exhib-
ited collagen deposition in diaphyseal defects. Newly de-
posited collagen fibre alignment was similar to that of
native mineralised tissues. New matrix formation in epi-
physeal defects was reminiscent of diaphyseal tissue rather
than epiphyseal tissue. Birefringence imaging revealed col-
lagen alignment similar to that of native bone collar in
Stro-1 immuno-selected pellets implanted in epiphyseal
defects. Differentiation capacity and matrix deposition in
unsorted and Stro-1 immuno-selected foetal populations
were similar to that observed in adult populations
Fig. 3 Molecular analysis of gene expression in epiphyseal and diaphyseal populations cultured as 3D pellets. Pellets (2.5 × 105 cells per pellet)
were cultured in basal medium for 21 days prior to analysis of osteochondral genes including RUNX2 a, ALP b, COL1A1 c, ON d, COL10A1 e,
SOX9 f and COL2A1 g. Error bars are SD. * P≤ 0.05, ** P ≤ 0.01 (foetal samples, n = 3; 55, 56 and 63 days post conception)
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Fig. 4 In vitro characterisation of epiphyseal and diaphyseal 3D pellet cultures. 2.5 × 105 cells per pellet (P2) were cultured in basal medium for
48 h before transfer to differentiation medium for 21 days in organotypic culture. Diaphyseal pellets were cultured in basal and osteogenic
medium, whilst epiphyseal pellets were cultured in basal and chondrogenic medium. Specific ALP activity was also assessed following 21 days
culture. Scale bars measure 200 μm. (foetal samples, n = 6; 55, 55, 56, 63, 63 and 65 days post conception). ALP alkaline phosphatase
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(Additional file 9: Figure S8). Adult unsorted pellets exhib-
ited minimum collagen deposition in both epiphyseal and
diaphyseal defects, whilst adult Stro-1 pellets exhibited
new collagen deposition with fibre alignment similar to
that in native bone collar.
Discussion
The current study has characterised both regional and
immuno-selected skeletal cell populations derived from
human foetal femora. These populations offer tools for
both in vitro and ex vivo interrogation of the biological
mechanisms controlling skeletal development and bone
formation. Understanding these mechanisms using foetal
populations as a developmental paradigm will inevitably
inform successful in vivo tissue engineering strategies
leading to improved bone formation and defect reparation
downstream. Careful dissection through the metaphyses
resulted in two regional populations, epiphyseal and di-
aphyseal cells. Distinction between the epiphysis and di-
aphysis is not clear as the metaphysis is a transitional zone
between the two regions. The authors are aware that a
simplified dissection approach to cell isolation may lead to
cross-contamination of epiphyseal and diaphyseal popula-
tions. Indeed, further investigation revealed the presence
of a shared sub-population of cells between both regions
exhibiting Stro-1 expression, indicating a potential SSC
source. Nevertheless, this study shows the osteochondral
differentiation potential of these distinct foetal femur pop-
ulations and their contribution to skeletal development
and repair by means of a bone defect model.
2D in vitro characterisation revealed an osteogenic
phenotype in diaphyseal populations (enhanced bone nod-
ule formation) and a distinct chondrogenic phenotype in
epiphyseal populations (enhanced proteoglycan and
mucopolysaccharide deposition) indicative of the SSC
maturation stages expected within these respective re-
gions. Early markers of osteogenic differentiation capacity
(ALP, COL1A1, RUNX2 and OSX) were observed to be
higher in diaphyseal populations. As would be expected
with early osteogenic differentiation, expression of late
markers such as OCN, was not increased. However, an
alternative mid-late osteogenic marker ON was signifi-
cantly increased indicating the presence of a sub-
population of diaphyseal cells that had become fully
differentiated and functional osteoblasts in the 14 day
culture period. It is important to note here that al-
though OCN expression was not significantly increased
in diaphyseal populations, expression was still observed
Fig. 5 Ex vivo bone defect regeneration following implantation of diaphysis-derived a and epiphysis-derived b 3D cell pellets. Pellets (1.5 × 104 cells
per pellet [P2]) were implanted in drill defects (300 μm diameter) at both epiphyseal and diaphyseal locations on an embryonic day 11 chick femur,
and incubated for 10 days in organotypic culture in basal medium. Femora were fixed, embedded in wax, sectioned and stained with Alcian blue/
Sirius red and imaged for birefringence using polarising filters. Highly aligned collagen fibres in mineralised bone appeared red. Scale bars
measure 1 mm (low magnification images) and 100 μm (high magnification images). (foetal samples, n = 4; 54, 59, 63 and 65 days post conception)
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Fig. 6 (See legend on next page.)
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confirming the presence of mature osteoblasts. Expres-
sion profiles of early (increased SOX9 and COL2A1)
and late (reduced COL10A1) chondrogenic genes in
epiphyseal populations indicated elevated early chon-
drocyte differentiation. Higher COL10A1 expression in
diaphyseal populations indicated the presence of hyper-
trophic chondrocytes, important in the formation of
mineralised cartilage. Similar trends were observed fol-
lowing 3D pellet culture for osteogenic genes including
ALP, COL1A1 and RUNX2. However, unlike monolayer
cultures, expression of mid to late osteogenic genes was
not observed indicating the absence of terminal differenti-
ation. Indeed, expression of chondrogenic gene SOX9 was
not significantly different between epiphyseal and diaphy-
seal populations suggesting cartilaginous and pre-osteoid
formation was dominant. In support, COL10A1 expres-
sion was reduced in diaphyseal populations highlighting
the lack of hypertrophic chondrocytes important for min-
eralisation. Critically, the similarities and differences ob-
served may be due to separate maturation stages within
(See figure on previous page.)
Fig. 6 In vitro characterisation of Stro-1 immuno-selected populations. Isolated cell populations were seeded into CFU-F assay (1 × 102 cells/cm2)
over serial passage (P1 to P10) and cultured for 14 days in T25 cm2 flasks before fixation in 85 % ethanol and staining for ALP expression a (n = 4;
55, 55, 55 and 56 days of age foetal samples). ALP+ colonies are presented as a percentage of the total number of colonies counted b. Population
doubling rate (c, foetal samples, n = 6; 55, 55, 55, 55, 56 and 56 days post conception), a measurement of proliferation, and specific ALP activity (d,
foetal samples, n = 4; 55, 55, 56 and 56 days of age post conception) were also assessed over serial passage in monolayer cultures seeded at 1 × 103
cells/cm2 (P2). Specific ALP activity was also assessed in cell populations (P2) following 14 days culture in basal or osteogenic medium (e, foetal
samples, n = 3; 55, 56, and 59 days (Stro-1); 55, 55 and 61 days (unsorted) of age post conception). Additional monolayer cultures (1 × 103 cells/cm2, P2)
were treated with osteogenic and adipogenic (rosiglitazone) medium for 14 days, and stained with Alizarin red f and Oil Red O g, respectively. Micro-
mass cultures (2.5 × 105 cells per pellet, P2) were treated with chondrogenic medium for 14 days and stained with Alcian blue h. Control
monolayers were cultured in basal medium. Representative images were of Stro-1 immuno-selected cultures in differentiation media. Error
bars are SD. *** P ≤ 0.001 (foetal samples, n = 3; 55, 56 and 59 days (Stro-1); 55, 55 and 61 days (unsorted) of age post conception). ALP
alkaline phosphatase
Fig. 7 Ex vivo bone defect regeneration following implantation of Stro-1 a and unsorted b 3D pellets. Pellets (1.5 × 104 cells per pellet [P2]) were
implanted in drill defects (300 μm diameter) at both epiphyseal and diaphyseal locations on an embryonic day 11 chick femur, and incubated for
10 days in organotypic culture in basal medium. Femora were fixed, embedded in wax, sectioned and stained with Alcian blue/Sirius red and
imaged for birefringence using polarising filters. Highly aligned collagen fibres in mineralised bone appeared red. Scale bars measure 1 mm (low
magnification images) and 100 μm (high magnification images). (foetal samples, n = 3; 55, 55 and 56 days (Stro-1); 55, 55 and 61 days (unsorted)
of age post conception)
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the respective populations. As such, further investigation
over serial passage would be required to assess the stabil-
ity of epiphyseal and diaphyseal population phenotypes.
Histological analysis revealed mineralisation in diaphy-
seal pellets and SOX9 expression in epiphyseal pellets.
Counter-intuitively, COL1A1 and COL2A1 deposition
was observed in both epiphyseal and diaphyseal pellets,
although a shared sub-population and rapid develop-
mental background offers some explanation as to why
both regional derived populations exhibited expression
of both osteogenic and chondrogenic markers. It is im-
portant to note that cross-contamination of populations
during isolation may also explain the dual expression of
COL1A1 and COL2A1. Both cell origin and implant-
ation site correlated with defect regeneration capacity;
epiphyseal and diaphyseal populations exhibited differ-
entiation plasticity dependent upon their environment,
suggesting the presence of a shared inducible sub-
population of progenitor cells.
Developmental stage-dependent Stro-1 expression
(adult SSC marker [5, 65, 66]) was observed in human
foetal femora in the epiphyses and the diaphysis, support-
ing the presence of a shared SSC sub-population. Interest-
ingly, Stro-1 immuno-selected populations exhibited
phenotype stability over prolonged passage, unlike their
adult Stro-1 counterparts which lose expression after a
single in vitro passage. Encouragingly, Stro-1 expression
correlated with multi-lineage differentiation potential at
early (P2) and late (P6) passage. Expression also appeared
to correlate with decreased cell proliferation and ALP+
colony formation, indicating possible emergence of a clo-
nogenic fibroblastic phenotype, often observed in pro-
longed in vitro cultures [67].
Without exogenous induction, Stro-1 immuno-selected
populations exhibited strong differentiation potential to-
wards the osteogenic lineage; this may explain why Stro-1
implants displayed only bone-like tissue formation. Un-
sorted populations demonstrated similar differentiation po-
tential to Stro-1 immuno-selected populations. However,
this did not translate to functional tissue regeneration,
evidenced by reduced new collagen and proteoglycan de-
position. This may be due to the lack of inductive signals
in vivo for unsorted populations, whereas Stro-1 immuno-
selected populations represent cell populations already
committed to the osteochondral differentiation path. Foetal
Stro-1 pellets demonstrated similar differentiation capacity
to their adult Stro-1 counterparts; both exhibited osteo-
genic differentiation potential independent of implantation
site. This may be due to underlying mechanisms and envir-
onmental factors in 3D pellet cultures that drive differenti-
ation along the osteogenic lineage.
Interestingly, both regional populations and Stro-1
immuno-selected populations isolated from human foetal
femora clearly demonstrated capacity for multi-lineage
differentiation and formation of new matrix reminiscent
of bone, cartilage and fat. However, to fully determine
their capacity for functional tissue regeneration and,
therefore, their application as an investigative tool, further
in vivo experimentation is required.
Conclusions
The current study demonstrates isolation of distinct cell
populations from human foetal femora according to ana-
tomical location and immuno-selection. Regionally derived
populations from the epiphyses and diaphysis offer poten-
tial cell sources for routine chondrogenic and osteogenic
differentiation, respectively. A shared SSC sub-population,
however, affords both epiphyseal and diaphyseal popula-
tions a degree of differentiation plasticity. Stro-1 enrich-
ment isolated an SSC alternative to their conventional
adult counterparts. However, to fully understand the tissue
regenerative capacity of these distinct populations, further
investigation is required to assess functional tissue forma-
tion in vivo. The work presented here shows that foetal
femur-derived populations offer investigative tools with
which to understand biological mechanisms involved in
skeletal development and their translation to regenera-
tive medicine. Furthermore, ex vivo assessment of these
populations provides a novel system with which to
screen potential tissue engineering strategies prior to
time consuming (and expensive) in vivo studies.
Additional files
Additional file 1: Figure S1. Human foetal femur following dissection
and removal of surrounding soft tissues (A) and an x-ray radiograph (B).
Red lines depict metaphyseal regions. White lines depict the epiphyseal and
diaphyseal regions. (foetal sample; 65 days post conception). (JPEG 831 kb)
Additional file 2: Table S1. Forward and reverse primer sequences
used for quantitative RT-PCR analysis. (JPEG 1068 kb)
Additional file 3: Figure S2. Control defect generation on embryonic
day 11 chick femora in organotypic culture. Drill defects (300 μm
diameter) were created along the length of the femur and restricted to
the epiphyses and diaphysis prior to pellet implantation. Control sham
defects were created and chick femora were organotypically cultured
for 10 days. (JPEG 1137 kb)
Additional file 4: Figure S3. Correlation between seeded cell number
and 3D pellet diameter. Human foetal femur derived cells were suspended
in basal medium and centrifuged at 1,000 rpm for 4 min to form pellets. 3D
pellets were subsequently cultured in basal medium for 48 h. Pellets were
formed from a range of cell numbers (1 × 104 to 1 × 106 cells). Following
pellet formation and incubation, pellets were imaged by light microscopy
and their diameter recorded. Error bars show SD. (foetal samples, n = 3; 54,
54 and 63 days of age post conception). (JPEG 381 kb)
Additional file 5: Figure S4. Development of human foetal femora and
bone collar formation. Human foetal femora covering a range of
developmental stages from 47 to 69 days post conception were fixed,
embedded in wax, sectioned and stained with Alcian blue/Sirius red.
Femora increase significantly in size and exhibit both mineralisation and
marrow cavity formation. Scale bars measure 100 μm (high magnification
images) and 500 μm (low magnification images). (JPEG 3785 kb)
Additional file 6: Figure S5. Development of human foetal femora and
Stro-1 expression. Human foetal femora covering a range of developmental
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stages from 47 to 69 days post conception were fixed, embedded in wax,
sectioned and Stro-1 immuno-labelled. Stro-1 appeared dependent on
developmental stage with expression around 47 days and 59 to 61 days
post conception, largely restricted to the diaphysis (depicted as bright
brown stain). High magnification images of the femur at 47 days clearly
show Stro-1 expression in the diaphysis but not in the epiphysis. Negative
controls were stained without the primary antibody. Scale bars in epiphysis
and diaphysis individual images measure 100 μm. Scale bars in the femur
overview images measure 500 μm. (JPEG 3030 kb)
Additional file 7: Figure S6. Maintenance of Stro-1 expression following
MACS isolation over serial passage in vitro. Isolated cells were seeded into
12-well plates (1 × 103 cells/cm2) at each consecutive passage (P1 to P10),
and cultured for three to five days (for cell adhesion and proliferation)
before fixation in 4 % PFA. Monolayers labelled for Stro-1 expression,
counterstained with DAPI were imaged by fluorescence microscopy. Left
windows show fluorescence images and right windows show the same
images in brightfield. Scale bars measure 50 μm. (foetal samples, n = 3; 55,
55 and 56 days post conception). (JPEG 1864 kb)
Additional file 8: Figure S7. Differentiation potential of Stro-1
immuno-selected populations from human foetal femora over extended
passage. Isolated cells were seeded (1 × 103 cells/cm2) as monolayer
cultures and expanded to P2 (top two rows) and P6 (bottom two rows)
before differentiation in osteogenic and adipogenic (indomethacin)
medium for 14 and 28 days, respectively. Micromass pellets (2.5 × 105
cells per pellet) were formed in basal medium for 1 h before culture in
chondrogenic medium for 21 days. Control cultures were treated with basal
medium. Osteogenesis was assessed by ALP expression, chondrogenesis by
proteoglycan deposition (Alcian blue staining), and adipogenesis by lipid
deposition (Oil Red O staining). (foetal samples, n = 3; 55, 55 and 55 days
post conception). (JPEG 3635 kb)
Additional file 9: Figure S8. Ex vivo bone defect regeneration
following implantation of Stro-1 immuno-selected and unsorted cell
pellets derived from adult human bone marrow. Pellets (1.5 × 104 cells
per pellet (P2)) were implanted in drill defects (300 μm diameter) at
both epiphyseal and diaphyseal locations on an embryonic day 11
chick femur, and incubated for 10 days in organotypic culture in basal
medium. Femora were fixed, embedded in wax, sectioned and stained
with Alcian blue/Sirius red and imaged for birefringence using polarising
filters. Highly aligned collagen fibres in mineralised bone red. Scale bars
measure 100 μm. (n = 5; F54, F67, F71, M60 and M78 (Stro-1); F52, M46, M67,
M75 and M78 (unsorted)) M =male; F = female. (JPEG 1702 kb)
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